Raymond James & Associates Clovis Oncology, Inc. Transaction History

Raymond James & Associates

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$5.02 - $7.05 $69,762 - $97,973	-13,897 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$4.81 - $10.34 $66,844 - $143,694	13,897 New	13,897 $98,000
Q3 2017 Nov 13, 2017	SELL	$67.17 - $84.81 $509,215 - $642,944	-7,581 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	7,581	7,581 $710,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.